Press-release for stocks publishing date 2021 - 10

Prices are updated after-hours

Moderna Announces First Participant Dosed in Phase 3 Pivotal Registration Study of Its mRNA Cytomegalovirus (CMV) Vaccine
Published: 2021-10-26 (Crawled : 21:00) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M

| -70.31% | O: 0.86% H: 0.0% C: 0.0%
vaccine phase 3

Moderna Announces Swissmedic Authorizes Booster Dose of Moderna’s COVID-19 Vaccine
Published: 2021-10-26 (Crawled : 14:00) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M

| -70.31% | O: 0.86% H: 0.0% C: 0.0%
covid vaccine covid-19

Moderna Announces Memorandum of Understanding to Supply up to 110 Million Doses of Its COVID-19 Vaccine to the African Union
Published: 2021-10-26 (Crawled : 09:00) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M

| -70.31% | O: 0.86% H: 0.0% C: 0.0%
covid vaccine

56%

44%

INVO | $1.76 131.58% 56.82% 230M

SINT | $0.0365 59.39% 37.26% 470M

WISA 4 | $9.19 50.66% 33.7% 65M

EDBL | News | $6.73 47.91% 32.39% 13M

GCTK | $0.715 36.27% 26.62% 640K

TCON | $2.33 36.26% 26.61% 2M

TIRX | $0.48 6.43% 24.58% 4.8M

KZIA | $0.38 30.58% 23.42% 300K

VNDA | News | $5.23 29.14% 22.56% 24M

ATNF | $1.91 29.05% 22.51% 310K

Save your searches and get alerts when important news are released.